Oncolytic myxoma virus: The path to clinic

See on Scoop.itVirology and Bioinformatics from Virology.ca
Highlights•

MYXV is a candidate oncolytic virus with varying efficacies of oncolytic properties.

MYXV productively infects many classes of human cancer cells.

MYXV discriminates cancerous human myeloid cells from the normal CD34+ stem cells.

MYXV is an attractive ex vivo purging agent candidate for hematological malignancies.

MYXV possesses significant oncolytic potential for pancreatic cancer and gliomas.

 

 

See on www.sciencedirect.com

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.